Toronto Dominion Bank
DMAAR

Toronto Dominion Bank’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Toronto Dominion Bank’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88K Buy
800,000
+110,000
+16% +$11.4K ﹤0.01% 1811
2026
Q1 		$41.4K Sell
690,000
-313,000
-31% -$33.1K ﹤0.01% 1794
2025
Q4 		$188K Buy
1,003,000
+3,000
+0.3% +$582 ﹤0.01% 1482
2025
Q3 		$217K Sell
1,000,000
-945,600
-49% -$176K ﹤0.01% 1391
2025
Q2 		$234K Buy
+1,945,600
New +$250K ﹤0.01% 1276

Other funds holding DMAAR

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Toronto Dominion Bank's DMAAR Position: Q2 2026 in Review

Toronto Dominion Bank increased its Drugs Made In America Acquisition Corp Rights (DMAAR) stake by 16% in Q2 2026, buying an estimated $11.4K and bringing the position to 800,000 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #1811.

Toronto Dominion Bank first reported a position in DMAAR in Q2 2025 and has held it in 5 quarters since. The position peaked at $234K in Q2 2025. 28 funds tracked by Wall St. Rank hold DMAAR as of Q2 2026.

  • Toronto Dominion Bank held 800,000 shares of Drugs Made In America Acquisition Corp Rights worth $88K as of Q2 2026.
  • Toronto Dominion Bank bought 110,000 Drugs Made In America Acquisition Corp Rights shares in Q2 2026, an estimated $11.4K.
  • Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1811 holding.
  • Toronto Dominion Bank first reported a position in Drugs Made In America Acquisition Corp Rights in Q2 2025 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Drugs Made In America Acquisition Corp Rights position peaked at $234K in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.